Objective: The aim of this prospective study was to compare serum and urine concentrations of progesterone-induced blocking factor (PIBF) and serum concentrations of anti-inflammatory (IL10) and pro-inflammatory (IL6, TNFa, IFNg) cytokines of women with threatened spontaneous abortion with normal pregnancy and to evaluate the impact of PIBF on outcome of pregnancy. Methods: A sample of 30 women with threatened spontaneous abortion (study group) and 20 healthy pregnant women (control group) between 6 th and 24 th gestational weeks was studied. Serum and urine PIBF, IL10 and IL6, TNFa, IFNg cytokine concentrations were measured by enzyme-linked immunosorbent assay (ELISA). Results: Five (16.7%) pregnancies in the study group ended missed abortion vs. none in the control group (P-0.05). Five (20%) threatened aborters delivered between 24 th and 37 th weeks of gestation, whereas two (10%) preterm deliveries occurred in the controls (P)0.05). PIBF concentrations in urine (19.5"12.9 ng/mL) and serum (214.4"120.6 of patients with threatened abortion were significantly lower than in healthy pregnant women (45.3"33.7 ng/mL and 357.3" 159.9 ng/mL, respectively). Women with threatened abortion had significantly lower serum levels of antiinflammatory cytokine, but levels of proinflammatory cytokines were higher in this group compared with healthy controls. Conclusions: Determination of progesteron-induced blocking factor level in body fluids in early pregnancy might be used for the diagnosis and prognosis of threatened abortion.
Introduction
Pregnancy can be compromised by a number of complications such as threatened abortion, recurrent spontaneous miscarriage, and preterm delivery w20x. Spontaneous abortion is a common problem affecting 15-20% of all recognized pregnancies. Spontaneous miscarriages have a range of possible causes including genetic, anatomical, endocrine, immune, infective, thrombophilic, and unexplained w13x. A substantial part of unexplained spontaneous abortion might be attributable to a deleterious immune response of a mother toward the fetus. A growing body of evidence suggests that progesterone might play a role in establishing an adequate immune environment during the early stages of pregnancy w12, 25x. Particularly interesting are the effects of pro-inflammatory and anti-inflammatory cytokines on the conceptus and thus, on the success or failure of pregnancy w20x. In the presence of progesterone, lymphocytes of pregnant women release a protein named the progesterone-induced blocking factor (PIBF) w26x which mediates the immunomodulatory and anti-abortive effects of progesterone w28, 30, 31x. Immunologic recognition of pregnancy and subsequent activation of maternal immune system results in an upregulation of progesterone receptors on activated lymphocytes among placental cells and CD8q cells. In the presence of sufficient progesterone levels, these cells synthesize PIBF w32x. Patients at risk of spontaneous abortion have increased pro-inflammatory and low PIBF and IL-10 expressions on lymphocytes w35x. PIBF alters the profile of cytokine secretion of activated lymphocytes shifting the balance toward Th 2 dominance w33x. During normal uneventful pregnancy the concentration of PIBF continuously increased from the 6 th to the 37 th gestational week. After the 41 st week, PIBF concentrations dramatically decrease. In patients with threatened spontaneous abortion PIBF levels failed to increase during pregnancy w19x. Therapeutic regimens to prevent spontaneous abortion are limited in efficacy. Still, there is a considerable controversy about the use of progestogens for the treatment of threatened spontaneous abortion. There are four main approaches towards progestogen therapy: 1. Do nothing; 2. No routine therapy, but once or twice weekly measurements of progesterone levels to suggest whether support with progestogens is or is not necessary (the cut-off level is 300 nmol/L); 3. Routine pharmacological ''support of the pregnancy''. This is frequently advocated empirically in all pregnancies following recurrent losses because ''it can do no harm''. In our view, this is an unacceptable argument which has no place in ethical treatment regimens; 4. Treat only within properly designed prospective trials (with adequate follow-up). This is our preferred option w6x.
The aim of this prospective study was to compare serum and urine concentrations of PIBF and serum concentrations of anti-inflammatory (IL10) and pro-inflammatory (IL6, TNFa, IFNg) cytokines of women with threatened spontaneous abortion with normal pregnancy and to evaluate impact of PIBF on outcome of pregnancy as well as the possible underlying mechanisms.
Patients and methods
A prospective study was performed at the Clinics for Gynecology and Obstetrics, University-Clinical Center Tuzla and Counseling for pregnant women at the department for health protection of women at the Public Medical Center Tuzla. A study and control group of pregnant women were formed, as a consecutive sample, with a total of 50 examinations. Pregnant women aged 18-35 years, who had no risk factors for spontaneous abortion, were included in this research. The study group consisted of 30 pregnant women, who were hospitalized at the Department of Pathology of Pregnancy (Clinics for Gynecology and Obstetrics in Tuzla), but only those who were hospitalized due to threatened spontaneous abortion (between 6 th and 24 th weeks' gestation). Threatened spontaneous abortion was defined as bleeding, spotting and uterine cramps. A gestational age was determined in all patients by ultrasound examination. Exclusion criteria were: chronic diseases, e.g., hypertension, diabetes, renal or cardiac diseases, uncertain gestational age, previous spontaneous abortion, history of urinary infections in actual pregnancy, history of pregnancy loss, uterine anomalies and previous cesarean section. Only singleton pregnancies qualified for the study. The control group consisted of 20 healthy pregnant women from 6 th to 24 th gestation weeks who had no risk factors for spontaneous abortion and who underwent regular gynecological examinations. Serum and urine samples were collected from all subjects and PIBF concentration was measured by enzyme-linked immunosorbent assay (ELISA) w19x. The analysis was conducted at the Department of Microbiology and Immunology at Medical Faculty, University of Pecs, Hungary.
PIBF determination
Briefly, during overnight incubation at 48C, 96-well microtiter plates were coated either with ani-human recombinant PIBF IgG (100 mL/well of 2 mg/mL) in 50 mm carbonate buffer pH 9.6 (plate 1), or with human recombinant PIBF (100 mL of 0.5 mg/mL) in 0.5 m Tris buffer pH 6.5 (plate 2). For generating a standard curve, recombinat PIBF (1000-0.1 ng/mL) in logarithmic dilutions in 0.5 m phosphate buffer (pH 7.3-7.4) was incubated with a standard amount of biotin-labeled anti-recombinant PIBF IgG (400 ng) for 60 min at 378C. Serum and urine samples were diluted 1/2.5 and 1/5 and incubated with 400 ng biotinlabeled anti-recombinant PIBF IgG in 0.5 m phosphate-buffered saline (PBS) for 60 min at 378C before being added to ELISA plate 1. During the 1 h incubation at 378C, non-specific binding sites on plate 2 (coated with human recombinant PIBF) were blocked with 200 mL of 0.1% bovine serum albumin (BSA), 0.5% gelatin in PBS-Tween. After this incubation step, 100 mL standard solutions of the serum and urine samples were transferred from plate 1 to plate 2 and incubated for 1 h at 378C. After washing the plates three times with PBS-Tween, 100 mL of 1:1000 diluted horseradish peroxidase (HRPO)-conjugated streptavidine (AP Hungary Ltd, Budapest, Hungary) in 0.1% BSA PBS-Tween was added and plates were incubated for 30 min at 378C. The reaction was developed by adding the substrate orthophenylene-diamine (OPD; Sigma, Budapest, Hungary) and measured at 495 nm.
The concentrations of IL10, IL6, TNFa, IFNg were taken from blood samples and were measured manually with a quantitative sandwich enzyme immunoassay (ELISA) after freezing at -708C, centrifugation and aliquation at the Department of Immunology and Microbiology in Tuzla. Cytokine concentrations were measured in serum manually with a high sensitive quantitative sandwich enzyme immunoassay (R&D Systems Inc., Minneapolis, USA). The minimum detectable concentrations of human proinflammatory and anti-inflammatory cytokines were as follows: IL10 -3.9 pg/mL, IL6 -0.7 pg/mL, IFNg -8 pg/mL and TNFa -1.6 pg/mL. The intra-and inter-assay precision of the all cytokine assays were -10%. In the serum of pregnant women from the examined and control group values of IL6, IFNg, TNFa, IL10 were determined, and the analysis was conducted at the Department of Microbiology and Immunology, University Clinical Center Tuzla.
The study was approved by the Ethical Committee of the University Clinical Center Tuzla, Bosnia and Herzegovina (Decision No. 01/1-37-4-898/07). Every patient was provided with a written consent for participation. SPSS V.11.5 software (SPSS Inc, Chicago, Illinois, USA), Arcus Quick Stat and Microsoft Excel XP Professional were used for statistical analysis of the study. Student's t-test was used to compare the mean values. The distribution of qualitative variables was compared by x 2 or by Fisher's exact tests. A value of two-sided P-0.05 was considered significant.
Results
Fifty patients were included in this study, without difference between clinical characteristics in women with preterm delivery and healthy pregnant controls in maternal age or gestational age at the time of enrollment. The mean gestational age at the time of blood sampling was also not different. Active smoking was declared by 20% in both groups (Table 1) .
Five (16.7%) pregnancies with threatened abortion ended in missed abortion. No missed abortion was registered in the control group (difference was statistically significant). Five (20%) women with threatened abortion delivered between 24 th and 37 th weeks' gestation, where- Threatened abortion Healthy controls P-value Mean"SD Mean"SD IL10 serum (pg/mL) 6.7"4.7 7.9"4.9 -0.05 IL6 serum (pg/mL) 3.7"1.4 1.3"1.0 -0.05 TNFa serum (pg/mL) 8.4"3.4 6.7"0.6 -0.05 IFNg serum (pg/mL) 9.6"1.8 7.6"2.6 -0.05 ILsinterleukin, TNFstumor necrosis factor, IFNsinterferon. as two (10%) with preterm delivery were registered in the control group. There was no significant difference in preterm deliveries between the study and control group (Table 2) .
PIBF concentrations in urine (19.5"12.9 ng/mL) and serum (214.4"120.6) samples of patients showing clinical symptoms of threatened abortion were significantly lower than in those of healthy pregnant women (45.3"33.7 ng/mL; 357.3"159.9 ng/mL, Table 3 ) Using a cut-off level of 20.7 ng/mL, PIBF urine concentrations predicted pregnancy termination with sensitivity 63%, specificity 90%, positive predictive value 91%, and negative predictive value 90%, whereas a cut-off level of 182.8 ng/mL PIBF serum concentrations predicted pregnancy termination with sensitivity 53%, specificity 95%, positive predictive value 94%, and negative predictive value 95%.
Women with symptoms of threatened spontaneous abortion had significantly lower serum levels of antiinflammatory cytokine (IL10), but levels of proinflammatory (IL6, TNFa, IFNg) cytokines were higher in this group compared to healthy controls (Table 4) .
Discussion
This study shows that PIBF concentrations in body fluids from pregnant women reflects certain pathological events and is related to outcome of pregnacy. There is ample evidence that PIBF is relevant for maintenance of pregnacy and its actions are exerted through immunological mechanisms such as altered Th 1 /Th 2 cytokine balance w29, 33x. All patients during hospitalization due to threatened miscarriage received gestagen therapy.
Premature delivery of 5 (20%) patients in our study took place after they were released from the clinics and stopped gestagen therapy. Sanches-Ramos et al. w21x published a randomized study that was conducted among 1339 patients to establish the efficiency of progesterone therapy on prevention of premature deliveries. They showed that gestagen (17-a hydroprogesteron and other types of progesterone) lowered the risk of premature delivery and delivery of newborns with low birth weight in patients with a history of early miscarriages and threatened miscarriage in the current pregnancy. Similar results found by Sfakianki and Norwitz w23x, Szekeres-Bartho et al. w34x and Kalinka and Bartho w12x, who determined the therapeutic effect of progesterone through PIBF in patients with symptoms of threatened miscarriage, noted that induction of production PIBF by Dydrogesteron significantly reduces the frequency of miscarriages. Similar conclusions were reached by other authors, in agreement with results of our study w3, 7x.
We found significantly higher concentration of proinflammatory cytokines in patients with threatened spontaneous abortion, in accord with studies conducted by many authors w3, 7, 19, 36x. Most authors conclude that IL10 has the key anti-inflammatory immune response w2, 5, 19x. Palfi et al. w16x did not find a difference between healthy pregnant women and controls when the serum ratio of Th 1 /Th 2 cytokines was measured in patients with habitual miscarriages, and suggested a crucial impact on outcome of pregnancy by a ratio between proinflammatory and anti-inflammatory cytokines. Sedlmayr w22x found higher IL6 concentration produced by macrophages in decidual cells in patients with repeated miscarriages, in accord with our research. Similar results were noted by other authors w9, 10x. These results are different from Wolff et al. w37x and Baek w1x who noted lower IL6 values in serum of patients with idiopathic miscarriages. TNFa belongs to the group of proinflammatory cytokines and it inhibits placental differentiation and invasion, laying down the extracellular matrix, hormone production, deactivation of macrophages and inhibits the production of cytokines in many tissues. These are actually pathophysiological mechanisms that lead to miscarriage w8, 15, 24x. Many authors noted a direct influence of higher TNFa values on development of miscarriages w2, 5, 14x. Interferon gamma belongs to the group of proinflammatory cytokines which was the subject of much research on immunological causes of miscarriages w4x. Most authors found direct connection between higher serum and local concentration (fetomaternal units) INFg in patients with miscarriages, which was found in this study as well w5, 9, 11, 17, 27x. Contrary to our study, some studies did not find an influence of higher serum concentration of INFg on development of miscarriage w16, 18x.
We conclude that (1) concentrations of PIBF in urine and serum are significantly lower in pregnant women with threatened miscarriage; (2) concentration of anti-inflammatory cytokine (IL10) in serum is significantly lower, and concentration of proinflammatory cytokines (IL6, IFNg, TNFa) is significantly higher in pregnant women with symptoms of threatened miscarriage; (3) determination of concentration PIBF in urine and in serum, as well as IL6, IFNg, TNFa and IL10 cytokines in serum might be used as a diagnostic and prognostic parameter of threatened abortion.
